Transgenic overexpression of human islet amyloid polypeptide inhibits insulin secretion and glucose elimination after gastric glucose gavage in mice

Diabetologia

Volumn 41, Issue 11, 1998, Pages 1374-1380

  Ahren B ^a,c   Oosterwijk, C ^b   Lips, C J M ^b   Hoppener J W M ^b  

^a LUND UNIVERSITY   (Sweden)

^b UTRECHT UNIVERSITY   (Netherlands)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Amylin; Glucose elimination; Glucose tolerance; IAPP; Insulin secretion; Transgenic mice

Indexed keywords

AMYLIN; GLUCOSE; INSULIN;

ADOLESCENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GENE OVEREXPRESSION; GLUCOSE INTAKE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE TEST; INSULIN RELEASE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

AMYLOID; ANIMALS; BLOOD GLUCOSE; ENTERAL NUTRITION; FASTING; FEMALE; GLUCOSE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; MALE; MICE; MICE, TRANSGENIC; RECOMBINANT PROTEINS; SEX CHARACTERISTICS;

EID: 0031769349     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051079     Document Type: Article

References (35)

1. Westermark P, Wernstedt C, Wilander E, Hayden DW, O'Brien TD, Johnson KH (1987) Amyloid fibrills in human insulinoma and islets of Langerhans in the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. Proc Natl Acad Sci USA 84: 3881-3885
2. Kanatsuka A, Makino H, Ohsawa H et al. (1989) Secretion of islet amyloid polypeptide in response to glucose. FEBS Lett 259: 199-201
3. Lukinius A, Wilander E, Westermark GT, Engström U, Westermark P (1989) Colocalization of islet amyloid polypeptide and insulin in the B cell secretory granules of the human pancreatic islets. Diabetologia 32: 240-244
4. Kahn SE, D'Alessio DA, Schwartz MW et al. (1990) Evidence of cosecretion of islet amyloid polypeptide and insulin by beta cells. Diabetes 39: 634-638
5. Denijn M, De Weger RA, van Mansfeld AD, van Unnik JA, Lips CJ (1992) Islet amyloid polypeptide (IAPP) is synthesized in the islets of Langerhans. Detection of IAPP polypeptide and IAPP mRNA by combined in situ hybridisation and immunohistochemistry in rat pancreas. Histochemistry 97: 33-37
6. Ahrén B, Sundler F (1992) Localization of calcitonin gene-related peptide and islet amyloid polypeptide in the rat and mouse pancreas. Cell Tissue Res 269: 315-322
7. Degano P, Silvestre RA, Salas M, Peiro E, Marco J (1993) Amylin inhibits glucose-induced insulin secretion in a dose-dependent manner. Study in the perfused rat pancreas. Regul Pept 43: 91-96
8. Ar'Rajab A, Ahrén B (1991) Effects of amidated rat islet amyloid polypeptide on glucose-induced insulin secretion in vivo and in vitro in rats. Eur J Pharmacol 192: 443-445
9. Wagoner PK, Chen C, Worley JF, Dukes ID, Oxford GS (1993) Amylin modulates beta-cell glucose sensing via effects on stimulus-secretion coupling. Proc Natl Acad Sci USA 90: 9145-9149
10. Fürnsinn C, Leuvenink H, Roden M et al. (1994) Islet amyloid polypeptide inhibits insulin secretion in conscious rats. Am J Physiol 267:E300-E305
11. Bretherton-Watt D, Gilbey SG, Ghatei MA, Beacham J, Macrae AD, Bloom SR (1992) Very high concentrations of islet amyloid polypeptide are necessary to alter the insulin response to intravenous glucose in man. J Clin Endocrinol Metab 74: 1032-1035
12. Wang ZL, Bennet WM, Ghatei MA, Byfield PG, Smith DM, Bloom SR (1993) Influence of islet amyloid polypeptide and the 8-37 fragment of islet amyloid polypeptide on insulin release from perifused rat islets. Diabetes 42: 330-335
13. Leighton B, Cooper GJS (1988) Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vitro. Nature 335: 632-635
14. Koopmans SJ, van Mansfeld ADM, Jansz HS (1991) Amylin-induced in vivo insulin resistance in conscious rats: the liver is more sensitive to amylin than peripheral tissues. Diabetologia 34: 218-224
15. Young AA, Rink TJ, Wang MW (1993) Dose-response characteristics for the hyperglycemic, hyperlactemic, hypotensive and hypocalcemic actions of amylin and calcitonin gene-related peptide-I (CGRP-α) in the fasted anesthetized rat. Life Sci 52: 1717-1726
16. Tedstone AE, Nezzer T, Hughes SJ, Clark A, Matthews DR (1990) The effect of islet amyloid polypeptide (amylin) and calcitonin gene-related peptide on glucose removal in the anaesthetized rat and on insulin secretion from rat pancreatic islets in vitro. Biosci Rep 19: 339-345
17. Broderick CL, Brooke GS, DiMarchi RD, Gold G (1991) Human and rat amylin have no effects on insulin secretion in isolated rat pancreatic islets. Biochem Biophys Res Commun 177: 932-938
18. Wilding JP, Khandan Nia N, Bennet WM et al. (1994) Lack of acute effect of amylin (islet associated polypeptide) on insulin sensitivity during hyperinsulinaemic euglycaemic clamp in humans. Diabetologia 37: 166-169
19. Clark A (1992) Islet amyloid: an enigma of type 2 diabetes. Diabetes Metab Rev 8: 117-132
20. Westermark P, Johnson KH, O'Brien TD, Betsholtz C (1992) Islet amyloid polypeptide - a novel controversy in diabetes research. Diabetologia 35: 297-303
21. Höppener JWM, Verbeek JS, de Koning EJP et al. (1993) Chronic overproduction of islet amyloid polypeptide (IAPP)/amylin in transgenic mice: lysosomal localization of human IAPP and lack of marked hyperglycaemia or hyperinsulinaemia. Diabetologia 36: 1258-1265
22. van Hulst KL, Born W, Muff R et al. (1997) Biologically active human islet amyloid polypeptide/amylin in transgenic mice. Eur J Endocrinol 136: 107-113
23. Janson J, Soeller WC, Roche PC et al. (1996) Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide. Proc Natl Acad Sci USA 93: 7283-7288
24. Verchere CB, D'Alessio DA, Palmiter RD et al. (1996) Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide. Proc Natl Acad Sci USA 93: 3492-3496
25. Filipsson K, Pacini G, Scheurink AJW, Ahrén B (1998) PACAP stimulates insulin secretion but inhibits insulin sensitivity in mice. Am J Physiol 274:E834-E842
26. van Hulst KL, Hackeng WHL, Höppener JWM et al. (1994) An improved method for the determination of islet amyloid polypeptide levels in plasma. Ann Clin Biochem 31: 165-170
27. Putchler H, Sweat F, Levine M (1962) On the binding of Congo red by amyloid. J Histochem Cytochem 10: 355-364
28. Fox N, Schrementi J, Nishi M et al. (1993) Human islet amyloid polypeptide transgenic mice as a model of non-insulin-dependent diabetes mellitus (NIDDM). FEBS Lett 323: 40-44
29. Kahn SE, Bergman RN, Schwartz MW, Taborsky Jr GJ, Porte Jr D (1992) Short-term hyperglycemia and hyperinsulinemia imporove insulin action but do not alter glucose action in normal humans. Am J Physiol 262: E518-E523
30. Inoue K, Hisatomi A, Umeda F, Nawata H (1990) Amylin release from perfused rat pancreas in response to glucose and arginine. Diabetes Res Clin Pract 10: 189-92
31. Tokuyama T, Yagui K, Yamaguchi T et al. (1997) Expression of human islet amyloid polypeptide/amylin impairs insulin secretion in mouse pancreatic β cells. Metabolism 46: 1044-1051
32. 2, amylin, cholecystokinin, and other possible regulators of nutrient uptake. Metabolism 45: 1-3
33. MacDonald IA (1997) Amylin and the gastrointestinal tract. Diabet Med 14 [Suppl 2]:S24-S28
34. Thorens B (1995) Glucagon-like peptide-1 and control of insulin secretion. Diabetes Metab 21: 311-318
35. Göke R, McGregor GP, Göke B (1993) Amylin alters the biological action of the incretin hormone GLP-1(7-36)amide. Life Sci 53: 1367-1372